Discovery of a novel alpha isoform of the long-known enzyme LDHA provides new insights into cancer research
- 문서 유형
- 연구출판물 · 기타
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- FEBS JOURNAL292(9) · pp.2219 · 2025
- 피인용
- Web of Science 3Scopus 2
- FWCI (Scopus)
- 1.44
- JCR IF
- JCR 2024 4.2
- ISSN
- 1742-464X
저자
- 박원영제1저자Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, Gyeongsangnam D, South Korea
- Wei, ShiboGwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea
- Ryu, DongryeolGwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea
- 하기태교신저자Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, Gyeongsangnam D, South Korea
초록
Lactate dehydrogenase A is a key enzyme in energy metabolism, with significant roles in cancer progression. Huang et al. identified LDHAα, a novel LDHA isoform derived from an alternative transcript initiated at AUG198, producing a protein 3 kDa larger than canonical LDHA. LDHAα exhibits enhanced glycolytic activity and promotes glucose uptake, lactate production, and tumor growth more effectively than LDHA. Regulated by c-MYC and FOXM1, LDHAα is mainly cytoplasmic and serves as a potential cancer biomarker and therapeutic target. These findings highlight LDHAα's unique role in cancer metabolism and its potential for advancing targeted cancer therapies.
키워드
식별자
- Scopus EID
- 2-s2.0-86000302902
- WoS UID
- 001438605600001



로그인
연구물 목록으로